Abcam distribution agreement
May 12 2008 - 3:00AM
UK Regulatory
RNS Number : 0732U
Tepnel Life Sciences PLC
12 May 2008
FOR IMMEDIATE RELEASE
Tepnel Life Sciences plc ('Tepnel' or 'the Company')
Tepnel signs two year global distribution agreement with world's largest online
supplier of antibodies, Abcam
Manchester, U.K, 12th May 2008 Tepnel Life Sciences PLC (AIM: TED), the UK-based
international Molecular Diagnostics and Research Products & Services group,
announced today that it has signed a two year extension to its global licensing
agreement with Abcam (www.abcam.com), the world's largest online supplier of
antibody products. The agreement covers the worldwide distribution of Tepnel's
Diaclone range of diagnostic and research products and includes a guaranteed
annual minimum in sales. The move strengthens Tepnel's global reach through
ongoing access to a broad and growing range of customers from both academia and
industry.
Dr Allan Brown, Managing Director of Tepnel Research Products & Services
commented, "The continuing arrangement with Abcam is of strategic importance to
Tepnel. Key to the success of our Diaclone product range is rapid market access,
particularly for our newly developed products. Abcam's strong market presence
ensures that our products reach the broadest possible audience."
The distribution partnership with Abcam is a non-exclusive agreement for sales
globally. Tepnel will continue to sell direct to customers in France, UK & the
USA, and through its established distributor network.
Tepnel is fully committed to the development of immunological products designed
for therapy, diagnostic and research applications. The Diaclone range includes
products covering the fields of cytokines, and cytokine receptors, adhesion,
apoptosis and CD antigens. All Diaclone products are manufactured according to
ISO9001:2000 guidelines.
-End-
For Further Information:
Tepnel Life Sciences plc
Allan Brown, Managing Director, Tepnel Research Products & Services
0161 946 2200
Capital MS&L
Mary Clark or Joey Whineray
Tel: +44 20 7307 5330
Seymour Pierce Limited
Mark Percy
Tel: +44 20 7107 8000
Notes to Editors
About Tepnel Life Sciences plc
Tepnel Life Sciences (AIM:TED) is a UK-based international life sciences
products and services group with two main divisions, Molecular Diagnostics and
Research Products & Services. The Company has laboratories, manufacturing and
operations in the USA, UK and France with 215 employees. TLS provides test
kits, reagents and services to two highly synergistic markets, these being
Molecular Diagnostics and Biomedical Research. The company's strategy has been
to identify high growth niche opportunities within these multi-billion pound
markets. TLS focuses on these niche opportunities with internally developed
products, patents, expertise and know-how as well as strategic acquisitions, to
develop a leadership position within these defined market
segments.This information is provided by RNS
The company news service from the London Stock Exchange
END
STRUUUPAAUPRUBB
Ted Baker (LSE:TED)
Historical Stock Chart
From Jun 2024 to Jul 2024
Ted Baker (LSE:TED)
Historical Stock Chart
From Jul 2023 to Jul 2024